人类细胞染色体P450 3A4中有机分子合作结合的结构动态
Dan Fishelovitch1, Carina Hazan, Sason Shaik
1Department of Human Genetics, Sackler Institute of Molecular Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Journal of the American Chemical Society
|February 8, 2007
概括
细胞染色体P450 3A4 (CYP3A4) 酶动力学显示合作基质结合. 分子动力学揭示了效应分子稳定关键残留物,通过定位基质来优化药物代谢,以有效地抽取气.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞染色体P450 3A4 (CYP3A4) 代谢了50%的口服药物.
- CYP3A4表现出西格形动力学,表明具有合作性的基质结合.
- 这种合作有约束力的机制尚不清楚.
研究的目的:
- 阐明CYP3A4.4.中合作基质结合的机制.
- 了解效应基质如何影响活性部位和药物代谢.
- 调查特定残留物在CYP3A4合作结合中的作用.
主要方法:
- 用Diazepam对CYP3A4进行分子动力学模拟.
- 对具有无基质,单基质和双基质结合的酶适配体的分析.
- 检查残留物相互作用及其对基质方向的影响.
主要成果:
- 效应基质与活性基质和酶相互作用,重定向侧链.
- 残留物F304对于合作结合至关重要,在效应器结合时稳定其环境.
- 效应器的稳定导致活性基质在提取的过程中获得有利的方向.
结论:
- 在CYP3A4的合作结合是通过作用因子诱导的关键残留物如F304.4的稳定介导.
- 这种稳定优化了有效药物代谢的活性部位.
- 酶构成和残留物相互作用 (例如,R212-F304) 可以调节效应物的影响.
相关概念视频
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...

